Metabolic Dysregulation in Traumatic Brain Injury: Mechanisms, Clinical Implications, and Therapeutic Opportunities.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic pathways and therapeutic options without new empirical data or systematic review methodology.
PubMed 42233441 · doi:10.1177/08977151261452922
What was done
This review examined the secondary metabolic alterations that occur following traumatic brain injury (TBI). The authors summarized pathological mechanisms involving glucose and lipid processing, lactate accumulation, neurotransmitter dysregulation, and oxidative stress, and discussed potential interventions including pharmacological agents, nutritional strategies, and lifestyle modifications.
What was found
The abstract describes qualitative pathways of post-TBI metabolic impairment and lists potential therapeutic avenues. No quantitative findings, effect sizes, or specific clinical trial metrics are reported.
Why it matters
Secondary metabolic dysfunction is a major driver of post-TBI morbidity. Synthesizing these bioenergetic and biochemical pathways helps frame targets for metabolic and nutritional interventions aimed at improving recovery.
Limits
The paper is a non-systematic narrative review providing no primary clinical or experimental data. The abstract lacks quantitative measures and does not detail search methods, study inclusion criteria, or quality assessment of cited evidence.
Cited by
- supports Glucose metabolism and utilization in the brain are impaired following traumatic brain injury.